相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells
Sang-Min Kim et al.
BMB REPORTS (2019)
Matrix Metalloproteinases Promote Arterial Remodeling in Aging, Hypertension, and Atherosclerosis
Mingyi Wang et al.
HYPERTENSION (2015)
Recent insights into the cellular biology of atherosclerosis
Ira Tabas et al.
JOURNAL OF CELL BIOLOGY (2015)
Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation
H. Maxime Lagraauw et al.
ATHEROSCLEROSIS (2014)
Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis
Sima Allahverdian et al.
CIRCULATION (2014)
Smooth muscle cell phenotypic switch: implications for foam cell formation
Chiraz Chaabane et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
PTX3 Stimulates Osteoclastogenesis by Increasing Osteoblast RANKL Production
Eun-Jin Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
Bongkun Choi et al.
ONCOTARGET (2014)
Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis
Andrew James Murphy et al.
FRONTIERS IN IMMUNOLOGY (2014)
The intriguing mission of neuropeptide Y in the immune system
Mirjana Dimitrijevic et al.
AMINO ACIDS (2013)
Central hypotensive effects of neuropeptide Y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinase
Pei-Wen Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Endothelial dysfunction: the early predictor of atherosclerosis
Mashudu Mudau et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2012)
eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE-/- Mice
Padmapriya Ponnuswamy et al.
PLOS ONE (2012)
Of Mice and Men: Neuropeptide Y and Its Receptors Are Associated with Atherosclerotic Lesion Burden and Vulnerability
Lijun Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
Cholesterol Homeostasis and High-Density Lipoprotein Formation in Arterial Smooth Muscle Cells
Sima Allahverdian et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis
Svati H. Shah et al.
PLOS GENETICS (2009)
Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions
A. S. Savchenko et al.
JOURNAL OF PATHOLOGY (2008)
Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3
Alberto Mantovani et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
Lydia E. Kuo et al.
NATURE MEDICINE (2007)
Pro-inflammatory cytokines in acute coronary syndromes: From bench to bedside
Dimitris Tousoulis et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
TNFα-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK
B Han et al.
JOURNAL OF IMMUNOLOGY (2005)
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system
J Wheway et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
C-reactive protein in atherosclerotic lesions - Its origin and pathophysiological significance
HJ Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Peptide YY and neuropeptide Y induce villin expression, reduce adhesion, and enhance migration in small intestinal cells through the regulation of CD63, matrix metalloproteinase-3, and Cdc42 activity
M Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NPY and Y receptors: lessons from transgenic and knockout models
S Lin et al.
NEUROPEPTIDES (2004)
Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells
M Klouche et al.
ATHEROSCLEROSIS (2004)
The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation
E Napoleone et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Role of endothelial dysfunction in atherosclerosis
J Davignon et al.
CIRCULATION (2004)
Arterial smooth muscle cell heterogeneity - Implications for atherosclerosis and restenosis development
HY Hao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Characterization of the long pentraxin PTX3 as a TNFα-induced secreted protein of adipose cells
A Abderrahim-Ferkoune et al.
JOURNAL OF LIPID RESEARCH (2003)
Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Z Zukowska et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
VV Kunjathoor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Production of the long pentraxin PTX3 in advanced atherosclerotic plaques
MS Rolph et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells - A novel link between vascular inflammation and clotting activation
E Napoleone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Interactions of nitric oxide and peroxynitrite with low-density lipoprotein
H Rubbo et al.
BIOLOGICAL CHEMISTRY (2002)
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men
MK Karvonen et al.
ATHEROSCLEROSIS (2001)
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice
PJ Kuhlencordt et al.
CIRCULATION (2001)
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase
H Duplain et al.
CIRCULATION (2001)
Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling
S Kawashima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation
M Klouche et al.
CIRCULATION (2000)
Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes
RH Straub et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Enhanced atherosclerosis and kidney dysfunction in eNOS-/-Apo-/- mice are ameliorated by enalapril treatment
JW Knowles et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
